Clinical Trial Update: SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for insulin glargine (Lantus) in type 1 diabetes, with status reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 1 | Phase 4 | Status: COMPLETED